Pharmaniaga inks local manufacturing deal with Sinovac Biotech

A health worker shows a vial of Sinovac Biotech’s Coronavac during the vaccination of Philippine military at the national headquarters of the Philippine Army in Fort Bonifacio, Taguig City, Metro Manila, Philippines, on Tuesday (March 2, 2021). - Reuters

KUALA LUMPUR: Pharmaniaga Bhd has signed a local manufacturing agreement with China's Sinovac Biotech Ltd's subsidiary for the purchase of ready-to-fill bulk product of Covid-19 vaccine.

The company said on Monday its unit Pharmaniaga Lifescience Sdn Bhd (PLS) and Sinovac Life Sciences Co. Ltd had entered into the agreement on March 12 for the manufacturing of the vaccine by PLS.

Both parties will cooperate to do the filling and packaging from the ready-to-fill bulk product supplied by Sinovac Life Sciences in PLS' manufacturing plant in Malaysia.

Sinovac LS also agreed to exclusively authorise PLS to manufacture and distribute and supply the local finished product in Malaysia.

PLS will also obtain the conditional registration during disaster, product registration and/or marketing authorisation from the regulatory authorities in Malaysia for the local finished product and then market and distribute them in Malaysia.

On Jan 12, both parties had signed a binding term sheet where they would collaborate and manufacture the vaccine in Malaysia.